Side-by-side comparison of AI visibility scores, market position, and capabilities
Corning NY specialty glass and optical fiber (NYSE: GLW); upgraded Springboard plan $4B+ incremental sales by 2026 (20% op margin), 30% CAGR optical fiber for AI data centers, Gorilla Glass, competing with Prysmian and AGC.
Corning Incorporated is a Corning, New York-based specialty glass, ceramics, and optical physics company — publicly traded on the New York Stock Exchange (NYSE: GLW) as an S&P 500 Information Technology component — manufacturing optical fiber and cable (Optical Communications), display glass for LCD and OLED panels (Display Technologies), pharmaceutical glass packaging (Life Sciences), automotive emissions control substrate (Environmental Technologies), and Gorilla Glass for consumer electronics devices (Specialty Materials) through approximately 50,000 employees in 31 countries. In its upgraded "Springboard" growth plan, Corning set a target to add more than $4 billion in annualized sales (upgraded from the original $3 billion target) and achieve a 20% operating margin by end of 2026, with three primary drivers: 30% CAGR growth in the Optical Communications Enterprise segment serving AI data center connectivity, solar glass wafer revenue growth to $2.5 billion by 2028 (supplying advanced glass substrates for solar panels), and display glass pricing actions reflecting supply-demand rebalancing. The AI data center connectivity tailwind has accelerated Corning's optical communications growth — hyperscalers building out AI compute clusters (tens of thousands of GPU servers interconnected with high-bandwidth fiber networks) are driving demand for Corning's fiber optic cable products at unprecedented rates. CEO Wendell Weeks, who has led Corning since 2005, has managed the company through multiple technology transition cycles from CRT glass to LCD glass to fiber optics.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.